GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | £3.4B | £3.9B | £2.9B | £3.7B | £4.3B | £6.3B | £4.7B | £3.9B | £3.8B | £4.9B | £5.8B |
| Inventory | £5.9B | £5.7B | £5.5B | £5.1B | £5.8B | £6.0B | £5.9B | £5.5B | £5.6B | £5.1B | — |
| Current assets | £17.5B | £17.0B | £18.6B | £20.8B | £18.7B | £20.2B | £19.5B | £16.9B | £15.9B | £16.7B | — |
| Goodwill | £7.0B | £7.0B | £6.8B | £7.0B | £10.6B | £10.6B | £10.6B | £5.8B | £5.7B | £6.0B | £5.2B |
| Intangible assets | £16.7B | £15.5B | £14.8B | £14.3B | £30.1B | £29.8B | £31.0B | £17.2B | £17.6B | £18.8B | £16.7B |
| Total assets | £61.1B | £59.5B | £59.0B | £60.1B | £79.1B | £80.4B | £79.7B | £58.1B | £56.4B | £59.1B | — |
| Current liabilities | £21.4B | £21.7B | £21.1B | £22.8B | £23.7B | £22.1B | £24.1B | £22.5B | £26.6B | £19.0B | — |
| Long-term debt | £14.7B | £14.6B | £15.2B | £17.0B | £20.6B | £23.4B | £23.6B | £20.3B | £14.3B | £14.7B | — |
| Total liabilities | £45.2B | £46.4B | £46.2B | £50.1B | £57.8B | £59.6B | £61.3B | £54.4B | £52.9B | £54.1B | — |
| Shareholders' equity | £16.4B | £13.7B | £13.3B | £10.6B | £15.1B | £14.6B | £11.4B | £3.8B | −£68M | £1.1B | £8.9B |
| Shares outstanding | 4.32B | 4.31B | 4.31B | 4.31B | 5.39B | 5.39B | 5.38B | 5.38B | 5.37B | — | — |
| Current ratio | 0.82 | 0.78 | 0.88 | 0.91 | 0.79 | 0.91 | 0.81 | 0.75 | 0.60 | 0.88 | — |